Skip to content

Effect of Ultrasonic Activation of Bioceramic Sealer on Postoperative Pain in Lower Premolars

The Effect of Ultrasonic Activation of Bioceramic Sealer on Postoperative Pain in Teeth With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05289791
Enrollment
32
Registered
2022-03-21
Start date
2022-04-08
Completion date
2023-05-02
Last updated
2023-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic Irreversible Pulpitis

Brief summary

The aim of this study is to clinically compare post-operative pain levels after ultrasonic activation of Ceraseal bioceramic sealer versus non-activated bioceramic sealer for patients with symptomatic irreversible pulpitis related to mandibular premolar teeth.

Detailed description

To clinically compare post-operative pain levels after ultrasonic activation of Ceraseal bioceramic sealer versus non-activated bioceramic sealer for patients with symptomatic irreversible pulpitis related to mandibular premolar teeth.Ultrasonic activation of Ceraseal bioceramic sealer for 20 seconds using non cutting ultrasonic tip.

Interventions

OTHERultrasonic activation of bioceramic sealer

activation of bioceramic sealer using ultrasonic tip for 20 seconds in buccolingual and mesiodistal direction

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients above 18 years old and to 50. * Male or female. * Patients seeking root canal treatment. * Mandibular posterior teeth with Symptomatic irreversible pulpitis with preoperative sharp, moderate, or severe pain with normal periapical radiographic appearance or slight widening in lamina dura. * Systematically healthy patient (ASA I, II). * Patient who can understand modified VAS and sign informed consent

Exclusion criteria

* Medically compromised patients having significant systemic disorders. (ASA III or IV). * History of intolerance to NSAIDS. * Patients with two or more adjacent teeth requiring endodontic treatment. * External root resorption. * Internal root resorption. * Vertical root fracture. * Periapical lesion. * Association with swelling. * Acute peri-apical abscess or acute exacerbation of a chronic abscess. * Pregnancy. * Use of ibuprofen in the last 12 hour. * Bleeding disorder. * Long term corticosteroid use. * Mobility Grade II or III. * Pocket depth more than 5mm. * Previous root canal therapy. * Non-restorability. * TMJ problems, bruxism, clenching or traumatic occlusion. * Inability to perceive the given instructions

Design outcomes

Primary

MeasureTime frameDescription
postoperative pain6 hoursintensity of pain on modified Visual analogue scale

Secondary

MeasureTime frameDescription
number of analgesic tablets taken by patient after endodontic treatmentup to 48 hours postoperativelynumber of analgesics taken by patient in 1st 48 hours
Sealer Extrusion laterally and periapicallyImmediately after obturation.presence or absence of sealer extrusion

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026